Research output per year
Research output per year
Personal profile
Research interests
My research focus is to identify novel diagnostic and prognostic biomarkers for early and preclinical Alzheimer’s disease in cerebrospinal fluid (CSF), with Drs. David Holtzman, Anne Fagan, and Reid Townsend, director of the Proteomics Core Laboratory at WU. Clinically, I am a staff physician in the Division of Neuropathology, with a particular interest in neurodegenerative diseases.
Clinical interests
Postmortem diagnosis of neurodegenerative diseases
Fingerprint
Dive into the research topics where Richard Perrin is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Assessing subcortical, brainstem and cerebellar metabolic patterns using [18F]FDG PET-CT imaging in dementia with Lewy bodies
Alzheimer’s Disease Neuroimaging Initiative, 2026, (Accepted/In press) In: European Journal of Nuclear Medicine and Molecular Imaging.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: A route for cerebrospinal fluid flow through leptomeningeal arterial–venous overlaps enables macromolecule and fluid shunting (Nature Neuroscience, (2025), 28, 7, (1436-1445), 10.1038/s41593-025-01977-4)
Plog, B. A., Kim, K., Verhaege, D., Kim, M. W., Papadopoulos, Z., Dikranian, K., Dykstra, T., Cao, J., Perrin, R. J., Schwetye, K. E., Kipnis, J. & Drieu, A., Aug 2026, In: Nature neuroscience. 29, 8, p. 2048 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Blood-based circular RNAs for early diagnosis of Alzheimer’s disease
Phillips, B., Sanford, J., Janve, V. A., Liu, M., Johnson, M., Gong, K., Bergmann, K., Lowery, J., Flynn, A., Brock, W., Montejo, B. S., Sykora, N., Budde, J., Mellios, N., Papageorgiou, G., Sperling, R. A., Buckley, R. F., Seto, M., Morris, J. C. & Perlmutter, J. S. & 5 others, , Aug 2026, In: Nature medicine. 32, 8, p. 2857-2864 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Circulating lipids are related to longitudinal changes of ATN biomarkers for Alzheimer’s disease
Alzheimer’s Disease Neuroimaging Initiative & Alzheimer's Disease Metabolomics Consortium (ADMC), Sep 2026, In: Molecular Psychiatry. 31, 9, p. 5395-5408 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025)
for the Alzheimer's Disease Neuroimaging Initiative, Apr 2026, In: Alzheimer's and Dementia. 22, 4, e71353.Research output: Contribution to journal › Review article › peer-review
Open Access1 Link opens in a new tab Scopus citations